Literature DB >> 10768955

Functional flexibility of the FimH adhesin: insights from a random mutant library.

M A Schembri1, E V Sokurenko, P Klemm.   

Abstract

Type 1 fimbriae are surface organelles of Escherichia coli which mediate D-mannose-sensitive binding to different host surfaces. This binding is conferred by the minor fimbrial component FimH. Naturally occurring variants of the FimH protein have been selected in nature for their ability to recognize specific receptor targets. In particular, variants that bind strongly to terminally exposed monomannose residues have been associated with a pathogenicity-adaptive phenotype that enhances E. coli colonization of extraintestinal locations such as the urinary bladder. In this study we have used random mutagenesis to specifically identify nonselective mutations in the FimH adhesin which modify its binding phenotype. Isogenic E. coli clones expressing FimH variants were tested for their ability to bind yeast cells and model glycoproteins that contain oligosaccharide moieties rich in either terminal monomannose, oligomannose, or nonmannose residues. Both the monomannose- and the oligomannose-binding capacity of type 1 fimbriae could be altered by minor amino acid changes in the FimH protein. The monomannose-binding phenotype was particularly sensitive to changes, with extensive differences in binding being observed in comparison to wild-type FimH levels. Different structural alterations were able to cause similar functional changes in FimH, suggesting a high degree of flexibility to target recognition by this adhesin. Alteration of residue P49 of the mature FimH protein, which occurs within the recently elucidated carbohydrate-binding pocket of FimH, completely abolished its function. Amino acid changes that increased the binding capacity of FimH were located outside receptor-interacting residues, indicating that functional changes relevant to pathogenicity are likely to be due to conformational changes of the adhesin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10768955      PMCID: PMC97470          DOI: 10.1128/IAI.68.5.2638-2646.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Engineered iron oxide-adhesion mutants of the Escherichia coli phage lambda receptor.

Authors:  S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  Random mutagenesis of gene-sized DNA molecules by use of PCR with Taq DNA polymerase.

Authors:  Y H Zhou; X P Zhang; R H Ebright
Journal:  Nucleic Acids Res       Date:  1991-11-11       Impact factor: 16.971

3.  The fimD gene required for cell surface localization of Escherichia coli type 1 fimbriae.

Authors:  P Klemm; G Christiansen
Journal:  Mol Gen Genet       Date:  1990-01

4.  Investigation of minor components of Escherichia coli type 1 fimbriae: protein chemical and immunological aspects.

Authors:  K A Krogfelt; P Klemm
Journal:  Microb Pathog       Date:  1988-03       Impact factor: 3.738

5.  Three fim genes required for the regulation of length and mediation of adhesion of Escherichia coli type 1 fimbriae.

Authors:  P Klemm; G Christiansen
Journal:  Mol Gen Genet       Date:  1987-07

6.  Immunoelectron microscopic analysis of elongation of type 1 fimbriae in Escherichia coli.

Authors:  M A Lowe; S C Holt; B I Eisenstein
Journal:  J Bacteriol       Date:  1987-01       Impact factor: 3.490

7.  Functional heterogeneity of type 1 fimbriae of Escherichia coli.

Authors:  E V Sokurenko; H S Courtney; S N Abraham; P Klemm; D L Hasty
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  A key role for type 1 pili in enterobacterial communicability.

Authors:  C A Bloch; B A Stocker; P E Orndorff
Journal:  Mol Microbiol       Date:  1992-03       Impact factor: 3.501

9.  Adherence characteristics to human small intestinal mucosa of Escherichia coli isolated from patients with diarrhea or urinary tract infections.

Authors:  T Yamamoto; K Fujita; T Yokota
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

10.  Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae.

Authors:  K A Krogfelt; H Bergmans; P Klemm
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

View more
  23 in total

1.  Characterization of FasG segments required for 987P fimbria-mediated binding to piglet glycoprotein receptors.

Authors:  B K Choi; D M Schifferli
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

2.  Characterization of Escherichia coli type 1 pilus mutants with altered binding specificities.

Authors:  S L Harris; P A Spears; E A Havell; T S Hamrick; J R Horton; P E Orndorff
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

Review 3.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

4.  Escherichia coli K1 RS218 interacts with human brain microvascular endothelial cells via type 1 fimbria bacteria in the fimbriated state.

Authors:  Ching-Hao Teng; Mian Cai; Sooan Shin; Yi Xie; Kee-Jun Kim; Naveed Ahmed Khan; Francescopaolo Di Cello; Kwang Sik Kim
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen.

Authors:  Per Klemm; Viktoria Roos; Glen C Ulett; Catharina Svanborg; Mark A Schembri
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  Escherichia coli isolates causing asymptomatic bacteriuria in catheterized and noncatheterized individuals possess similar virulence properties.

Authors:  Rebecca E Watts; Viktoria Hancock; Cheryl-Lynn Y Ong; Rebecca Munk Vejborg; Amanda N Mabbett; Makrina Totsika; David F Looke; Graeme R Nimmo; Per Klemm; Mark A Schembri
Journal:  J Clin Microbiol       Date:  2010-05-05       Impact factor: 5.948

7.  Effective assembly of fimbriae in Escherichia coli depends on the translocation assembly module nanomachine.

Authors:  Christopher Stubenrauch; Matthew J Belousoff; Iain D Hay; Hsin-Hui Shen; James Lillington; Kellie L Tuck; Kate M Peters; Minh-Duy Phan; Alvin W Lo; Mark A Schembri; Richard A Strugnell; Gabriel Waksman; Trevor Lithgow
Journal:  Nat Microbiol       Date:  2016-05-16       Impact factor: 17.745

8.  Biodiversity-based identification and functional characterization of the mannose-specific adhesin of Lactobacillus plantarum.

Authors:  Gabriele Pretzer; Johannes Snel; Douwe Molenaar; Anne Wiersma; Peter A Bron; Jolanda Lambert; Willem M de Vos; Roelof van der Meer; Mari A Smits; Michiel Kleerebezem
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

9.  A bivalent glycopeptide to target two putative carbohydrate binding sites on FimH.

Authors:  Thisbe K Lindhorst; Kathrin Bruegge; Andreas Fuchs; Oliver Sperling
Journal:  Beilstein J Org Chem       Date:  2010-08-24       Impact factor: 2.883

Review 10.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.